1. Home
  2. GANX vs CSTE Comparison

GANX vs CSTE Comparison

Compare GANX & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.80

Market Cap

76.4M

Sector

Health Care

ML Signal

HOLD

CSTE

Caesarstone Ltd.

HOLD

Current Price

$2.37

Market Cap

76.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
CSTE
Founded
2017
1987
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
76.4M
IPO Year
2021
2012

Fundamental Metrics

Financial Performance
Metric
GANX
CSTE
Price
$1.80
$2.37
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
684.8K
176.4K
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
N/A
EPS
N/A
N/A
Revenue
$55,180.00
N/A
Revenue This Year
N/A
$3.43
Revenue Next Year
N/A
$2.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.56
52 Week High
$4.34
$2.62

Technical Indicators

Market Signals
Indicator
GANX
CSTE
Relative Strength Index (RSI) 47.40 74.02
Support Level $1.66 $2.12
Resistance Level $2.15 $2.59
Average True Range (ATR) 0.14 0.20
MACD -0.00 0.03
Stochastic Oscillator 19.64 73.78

Price Performance

Historical Comparison
GANX
CSTE

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa), of which it derives maximum revenue from United States.

Share on Social Networks: